news

Sylus Co., Ltd. established a research joint venture between Samyoung Unitech and the Daegu Gyeongbuk Institute of Science and Technology.

본문

Sylus Co., Ltd., established in April 2019, is a research joint venture between Samyoung Unitech, the parent company of Sylus and the Daegu Gyeongbuk Institute of Science and Technology.


We are striving for the success of new drug development with the experience and capability of Samyoung Unitech and the investment of the Daegu Gyeongbuk Institute of Science and Technology. 


Beginning with the development of anemia treatment drugs, Sylus focuses on the development of remedies for degenerative neurological diseases.

We will be sharing our progress and current status on our website. If you have any questions, please feel free to contact us.

Thank you.